Pantheon Bioscience
Platform of Bacterial Defense Mechanism
Health Tech & Life Sciences
Non Active, Sep 2021 ceased to operate
Company Overview
Snapshot
Founded in December 2017 by Prof. Rotem Sorek, Pantheon Bioscience operates with 1–10 employees. The company has secured funding across two rounds from two investors. In April 2018, Pantheon Bioscience received funding from ExploreBio and M Ventures.
Business overview
Pantheon Bioscience develops molecular tools based on novel anti-phage defense systems discovered at the Weizmann Institute of Science. The company focuses on understanding the mechanisms of action of these systems to create biotechnological applications. Operating within the Health Tech & Life Sciences sector, Pantheon Bioscience serves the biotechnology industry with its molecular biology, microbiology, and genomics technologies.
Company Intelligence Q&A
- What is Pantheon Bioscience's primary focus?
- Pantheon Bioscience focuses on developing molecular tools derived from new anti-phage defense systems discovered by Professor Rotem Sorek's lab at the Weizmann Institute of Science.
- When was Pantheon Bioscience founded?
- Pantheon Bioscience was founded in December 2017.
- Which investors participated in Pantheon Bioscience's April 2018 funding round?
- In April 2018, Pantheon Bioscience received funding from ExploreBio and M Ventures.
- What is the status of Pantheon Bioscience?
- Pantheon Bioscience is currently non-active and ceased to operate in September 2021.
- Where is Pantheon Bioscience located?
- Pantheon Bioscience is located at HaKishon Street 18, Yavne, Israel.